Synergistic Composition Delivery System

A novel system integrating radiofrequency energy-based composition delivery with AI, IoT, blockchain, and novel materials to provide personalized, optimized, and secure treatment of occlusions in blood vessels or grafts.

Current methods and devices for treating occlusions in the body employ the use of balloon catheters or stents to deliver drugs to the inside of the blood vessel. However, these methods have limitations, such as inadequate drug delivery and lack of personalization. The present inventive concept addresses these limitations by integrating radiofrequency energy-based composition delivery with advanced technologies to provide a more effective and personalized treatment approach.

The Synergistic Composition Delivery System comprises a composition delivery device incorporating a radiofrequency energy source and a composition delivery element, which can be made of novel nanomaterials or biodegradable materials. The system is integrated with an AI-powered predictive analytics module to optimize composition delivery based on patient-specific data and real-time treatment outcomes. Additionally, the system utilizes a blockchain-based secure data storage system to record and track patient treatment data, and an IoT-enabled composition delivery device to facilitate personalized treatment protocols. The system also includes a cloud-based data analytics platform to monitor and optimize treatment outcomes in real-time, and a machine learning algorithm to analyze patient data and identify optimal composition delivery protocols.

The novelty of the present inventive concept lies in the synergistic integration of radiofrequency energy-based composition delivery with AI, IoT, blockchain, and novel materials. This integration provides a new and non-obvious approach to treating occlusions in blood vessels or grafts, offering improved efficacy, personalization, and security compared to existing methods.

Alternative embodiments of the Synergistic Composition Delivery System could include variations in the composition delivery element, such as using different materials or geometries. Additionally, the system could be adapted for use in different body regions or for treating different types of occlusions. The AI-powered predictive analytics module could also be modified to incorporate different algorithms or data sources.

The Synergistic Composition Delivery System has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular and interventional radiology. The system's ability to provide personalized and optimized treatment of occlusions could lead to improved patient outcomes and reduced healthcare costs. The market for this system is expected to be substantial, with potential applications in hospitals, clinics, and other healthcare settings.